Skip to main content
Healthy volunteersDrugPhase 1

What this study is

The primary objective of this study is to assess the safety and tolerability of single and multiple ascending doses of INS1033 in healthy participants.

What's being tested

  • INS1033

    Intervention · DRUG

  • Placebo

    Intervention · DRUG

Both interventions

Oral solution

Study details

Official title
A Phase 1, Randomized, Double-blind, Placebo-controlled, 2-Part Study to Assess Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of INS1033 in Healthy Participants
Sponsor
Insmed Incorporated
Conditions
Healthy Volunteers
Enrolling
116 people
Starts
2026-08-25
Est. completion
2027-03-22
Design
Double-blind, randomized, sequential groups, Phase 1
Record
View on ClinicalTrials.gov ↗